Skip to content
Meta-analysis Open access

Multi-ancestry genetic architecture of heart failure subtypes

Aug 2026 · Nature Communications · Vol 17 · 0 citations · 97 references
Medicine

TL;DR

The genetic basis of major heart failure subtypes across diverse populations is mapped, identifying shared and subtype-specific risk variants that may inform biology, risk prediction and future therapies.

Abstract

Heart failure (HF) affects 6.7 million people in the US and includes two major subtypes, HF with reduced ejection fraction (HFrEF) and HF with preserved ejection fraction (HFpEF), with distinct genetic architectures. We meta-analyze genome-wide association studies (GWAS) of 38,781 HFrEF cases, 38,163 HFpEF cases, and 526,135 controls across European, African, Hispanic, and Asian ancestries using the Million Veteran Program and Vanderbilt University DNA Databank (BioVU). We identify 46 genome-wide significant loci for HFrEF (9 novel) and 3 loci for HFpEF (1 novel). Four HFrEF loci are detected in African ancestry participants near CD36, SPI1, TRIM48, and SPNS3, with lead SNPs showing low risk-allele frequencies in European populations. In the all-cause HF meta-analysis (200,070 cases, 2,076,466 controls), we identify 136 loci (12 novel). Gene-based tests, tissue enrichment, transcriptome-wide association, and fine-mapping implicate vascular, metabolic, and TGF-β/Smad signaling pathways and nominate candidate causal genes, clarifying shared and subtype-specific risk across ancestries. This study maps the genetic basis of major heart failure subtypes across diverse populations, identifying shared and subtype-specific risk variants that may inform biology, risk prediction and future therapies.

Read PDF

Similar papers

Open access Aug 2026

Prevalence of Pathogenic Genetic Variants Across Heart Failure Etiologies in an Admixed Population.

These findings replicate a significant diagnostic yield of molecular genetic testing in individuals with dilated cardiomyopathy but extend the relevance of genetic testing beyond traditionally selected HF subgroups, and underscore the importance of including non-European and admixed populations in cardiovascular genomi...

I. Lima, Lucas Vieira Lacerda Pires, M. A. C. E. Silva et al. · 0 citations
Open access Sep 2026

Ancestry-Based Disparities in Cardiovascular Outcomes and Polygenic Risk Among Adults with Congenital Heart Disease in the All of Us Research Program.

The pooled disparity attenuated to the null after comorbidity adjustment, with chronic kidney disease accounting for 58.6% of the age- and sex-adjusted effect, but age-specific estimates opposed one another (adjusted OR 1.78 at 40, 0.66 at 80; interaction P<0.001); survivor selection may contribute at older ages.

Tobias K. Fuchs, Anthony Collura, R. Anandakrishnan · 0 citations
Open access Sep 2026

Decomposing population differences in type 2 diabetes through a high-resolution GWAS of ~600,000 individuals with East Asian ancestry

Type 2 diabetes (T2D) is a highly heterogeneous metabolic trait, with a higher prevalence in East Asians. Despite extensive genetic studies focusing mainly on Europeans, how genetic risk for T2D is distributed across biological pathways in East Asians in comparison with Europeans remains incompletely understood. Here,...

Kohei Saito, Hsing-Fang Lu, Tatsuhide Inoue et al. · 0 citations
Open access Sep 2026

A multiancestry polygenic risk score improves stratification in patients with hypertrophic cardiomyopathy

A multiancestry polygenic risk score for hypertrophic cardiomyopathy is developed and its association with the disease in a heterogeneous national population is demonstrated and support the integration of multiancestry PRSs into HCM risk assessment and prognostication.

Harshvir S. Bal, A. Pampana, Amrita Nayak et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.